Your session is about to expire
← Back to Search
Anti-VEGF Injection for Retinal Disease (COMFORT Trial)
COMFORT Trial Summary
This trial tests the safety and effectiveness of a new anti-VEGF injection compared to a standard one.
COMFORT Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.COMFORT Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am not pregnant, planning to become pregnant, or breastfeeding.I am currently getting steroid shots in my eye.I have been diagnosed with uveitis.I have had or currently have an eye infection inside the eyeball.I understand the study and can agree to participate.I am 18 or older and get eye injections for my vision.I have poor vision in one eye and receive injections in my better eye.I am using viscous lidocaine eye drops before eye injections.
- Group 1: IRX-101
- Group 2: 5% Povidone-iodine
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has the Federal Drug Administration sanctioned the use of IRX-101?
"IRX-101 is perceived to be highly safe, as evidenced by its 3 score on the Power scale. This reflects multiple rounds of data that validate efficacy and safety within Phase 3 trials."
Are there any opportunities to take part in this clinical experiment currently?
"Affirmative. Documentation available on clinicaltrials.gov reveals that this study, which was advertised since February 22nd 2023, is open to enrollment. The trial necessitates the recruitment of 240 volunteers from a single site."
How many individuals are being selected to partake in this research?
"Affirmative. According to the information on clinicaltrials.gov, this medical experiment began recruiting patients on February 22nd 2023 and was recently updated March 1st 2023. It is currently looking for 240 people from a single research site."
Share this study with friends
Copy Link
Messenger